"A new health order as part of the new social order": The strategic response of the WHO to its member states

Political Power and Social Theory

Volumn 23, Issue , 2012, Pages 65-100

  Chorev, Nitsan ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886826026     PISSN: 01988719     EISSN: None     Source Type: Book Series    
DOI: 10.1108/S0198-8719(2012)0000023008     Document Type: Article

References (62)

1. Abdelal, R. (2007). Capital rules: The construction of global finance. Cambridge: Harvard University Press.
2. Albert, S., & Whetton, D. A. (1985). Organizational identity. Research in Organizational Behavior, 7, 263-295.
3. Barnett, M., & Coleman, L. (2005). Designing police: Interpol and the study of change in international organizations. International Studies Quarterly, 49, 593-619.
4. Barnett, M., & Finnemore, M. (2004). Rules for the world: International organizations in global politics. Ithaca, NY: Cornell University Press.
5. Brown, T. M., Cueto, M., & Fee, E. (2006). The World Health Organization and the transition from 'International' to 'Global' public health. American Journal of Public Health, 96(1), 62-72.
6. Chwieroth, J. (2008). Normative change from within: The international monetary fund's approach to capital account liberalization. International Studies Quarterly, 52, 129-158.
7. Cueto, M. (2004). The origins of primary health care and selective primary health care. American Journal of Public Health, 94, 1864-1874.
8. Di Maggio, P. J. (1983). State expansion and organizational fields. In R. H. Hall & R. E. Ouinn (Eds.), Organizational theory and public policy (pp. 147-161). Beverly Hills, CA: Sage.
9. Di Maggio, P. J. (1991). Constructing an organizational field as a professional project: U. S. Art Museums, 1920-1940. In W. W. Powell & P. J. Di Maggio (Eds.), The new institutionalism in organizational analysis (pp. 267-292). Chicago, IL: University of Chicago Press.
10. Fazal, A. (1983). The right pharmaceuticals at the right prices: Consumer perspectives. World Development, 11(3), 265-269.
11. Frieden, J. (2006). Global capitalism: Its fall and rise in the twentieth century. New York, NY: Norton.
12. Gish, O. (1983). The relation of the new international economic order to health. Journal of Public Health Policy, 4(2), 207-221.
13. Glynn, M. A. (2000). When cymbals become symbols: Conflict over organizational identity within a symphony orchestra. Organization Science, 11(3), 285-298.
14. Goodrick, E., & Salancik, G. R. (1996). Organizational discretion in responding to institutional practices: Hospitals and cesarean births. Administrative Science Quarterly, 41(1), 1-28.
15. Goodstein, J. D. (1994). Institutional pressures and strategic responsiveness: Employer involvement in work-family issues. The Academy of Management Journal, 37(2), 350-382.
16. Harris, L. C., & Ogbonna, E. (1999). The strategic legacy of company founders. Long Range Planning, 32(3), 333-343.
17. Hawkins, D. G., & Jacoby, W. (2006). How agents matter. In D. G. Hawkins, D. A. Lake, D. L. Nielson & M. J. Tierney (Eds.), Delegation and agency in international organizations. New York, NY: Cambridge University Press.
18. Hawkins, D. G., Lake, D. A., Nielson, D. L., & Tierney, M. J. (Eds.). (2006). Delegation and agency in international organizations. New York, NY: Cambridge University Press.
19. Hurd, I. (2007). After anarchy: Legitimacy and power in the United Nations Security Council. Princeton, NJ: Princeton University Press.
20. Imber, M. F. (1989). The USA, ILO, UNESCO and IAEA: Politicization and withdrawal in the specialized agencies. London: Macmillan.
21. Jayasuriya, D., Griffiths, A., & Rigoni, R. (1984). Judgment reserved: Breast-feeding, bottlefeeding and the international code. Nawala, Sri Lanka: Asian Pathfinder.
22. Jepperson, R. (1991). Institutions, institutional effects, and institutionalism. In W. W. Powell & P. Di Maggio (Eds.), The new institutionalism in organizational analysis (pp. 143-163). Chicago, IL: University of Chicago Press.
23. Jolly, R. (1991). Adjustment with a human face: A UNICEF record and perspective on the 1980s. World Development, 19(12), 1807-1821.
24. Kanji, N., Hardon, A., Harnmeijer, J. W., Mamdani, M., & Walt, G. (Eds.). (1992). Drugs policy in developing countries. London: Zed Books.
25. Keohane, R. (1984). After hegemony: Cooperation and discord in the world political economy. Princeton, NJ: Princeton University Press.
26. Keohane, R., & Martin, L. L. (1995). The promise of institutionalist theory. International Security, 20(1), 39-51.
27. Krasner, S. D. (1985). Structural conflict: The third world against global liberalism. Berkeley, CA: University of California Press.
28. Lall, S. (1978). The growth of the pharmaceutical industry in developing countries: Problems and prospects. ID/204. Vienna: UNIDO.
29. Lee, K. (2009). The World Health Organization (WHO). London: Routledge.
30. Litsios, S. (2004). The Christian medical commission and the development of the World Health Organization's primary health care approach. American Journal of Public Health, 94(11), 1884-1893.
31. Luken, R. A. (2009). Greening an international organization: UNIDO's strategic responses. Review of International Organizations, 4, 159-184.
32. Mamdani, M. (1992). Early initiatives in essential drugs policy. In N. Kanji, A. Hardon, J. W. Harnmeijer, M. Mamdani & G. Walt (Eds.), Drugs policy in developing countries. London: Zed Books.
33. Mamdani, M., & Walker, G. (1986). Essential drugs in the developing world. Health Policy and Planning, 1(3), 187-201.
34. Manela, E. (2010). A pox on your narrative: Writing disease control into cold war history. Diplomatic History, 34(2), 299-323.
35. Mearsheimer, J. (1994). The false promise of international institutions. International Security, 19(3), 5-49.
36. Melanson, R. A. (1979). Human rights and the American withdrawal from the ILO. Universal Human Rights, 1(1), 43-61.
37. Melrose, D. (1983). Double deprivation: Public and private drug distribution from the perspective of the third world poor. World Development, 11(3), 181-186.
38. Murphy, C. (1984). Emergence of the NIEO ideology. Boulder, CO: Westview Press.
39. Najera, J. A. (1989). Malaria and the work of WHO. Bulletin of WHO, 67(3), 229-243.
40. Newell, K. (1988). Selective primary health care: The counter revolution. Social Science and Medicine, 26(9), 903-906.
41. Nielson, D., & Tierney, M. (2003). Delegation to international organizations: Agency theory and world bank environmental reform. International Organization, 57(2), 241-276.
42. Oliver, C. (1991). Strategic responses to institutional pressures. Academy of Management Review, 16(1), 145-179.
43. Packard, R. (1997). Malaria dreams: Postwar visions of health and development in the third world. Medical Anthropology, 17, 279-296.
44. Peretz, S. M. (1983). An industry view of restricted drugs formularies. Journal of Social and Administrative Pharmacy, 1(3), 130-133.
45. Pfeffer, J., & Salancik, G. R. (1978). The external control of organizations: A resource dependence perspective. New York, NY: Harper & Row.
46. Phelps, J. R. (1982). The new international economic order and the pharmaceutical industry. Food Drug Cosmetic Law Journal, 37, 200-211.
47. Powell, W. W. (1988). Institutional effects on organizational structure and performance. In L. G. Zucker (Ed.), Institutional patterns and organizations: Culture and environment (pp. 115-136). Cambridge: Ballinger.
48. Raviglione, M. C., & Pio, A. (2002). Evolution of WHO policies for tuberculosis control, 1948-2001. The Lancet, 359(9308), 775-780.
49. Reich, M. R. (1987). Essential drugs: Economics and politics in international health. Health Policy, 8, 39-57.
50. Sauvant, K. P. (Ed.). (1981). Changing priorities on the international agenda: The new international economic order. Oxford: Pergamon.
51. Scott, R. W. (2008). Approaching adulthood: The maturing of institutional theory. Theory and Society, 37, 427-442.
52. Sethi, S. P. (1994). Multinational corporations and the impact of public advocacy on corporate strategy: Nestle and the infant formula controversy. Boston, MA: Kluwer Academic Publishers.
53. Sikkink, K. (1986). Codes of conduct for transnational corporations: The case of the WHO/UNICEF code. International Organization, 40(4), 815-840.
54. Smith, D., & Bryant, J. H. (1988). Building the infrastructure for primary health care: An overview of vertical and integrated approaches. Social Science Medicine, 26(9), 909-917.
55. Suchman, M. (1995). Managing legitimacy: Strategic and institutional approaches. Academy of Management Review, 20(3), 571-610.
56. Thornton, P. H., & Ocasio, W. (1999). Institutional logics and the historical contingency of power in organizations: Executive succession in the higher education publishing industry, 1958-1990. American Journal of Sociology, 105(3), 801-843.
57. Walt, G., & Harnmeijer, J. W. (1992). Formulating an essential drugs policy: WHO's role. In N. Kanji, A. Hardon, J. W. Harnmeijer, M. Mamdani & G. Walt (Eds.), Drugs policy in developing countries. London: Zed Books.
58. Weaver, C. (2008). Hypocrisy trap: The World Bank and the poverty of reform. Princeton, NJ: Princeton University Press.
59. WHO. (1958). The first ten years of the World Health Organization. Geneva: WHO.
60. WHO. (1978). Declaration of Alma Ata: International Conference on Primary Health Care, Alma Ata, USSR, September 6-12, 1978. Geneva: WHO.
61. WHO. (1980). Technical discussions on the contribution of health to the new international economic order. A33/Technical Discussions/1. Geneva: WHO Library.
62. Williams, D. (1987). The specialized agencies for the United Nations: The system in crisis. London: Hurst.